Activity value 75International Buyer&Supplier,Last transaction date:
2026-06-22Address: no 273-a nanhai avenue national high-tech zone haikou hainan 570314 cn
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for qilu pharmaceutical hainan co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 21 transactions, with a transaction quantity of 2630.04 and a transaction weight of 14012.95.
YearTransactionsQuantityWeight
20254777117.1714752.54
2026212630.0414012.95
Bill of lading data
<
1/15
>
Trade date
2026/06/22
B/L No.
102664
Suppliers
qilu pharmaceutical hainan co.ltd.
Buyers
hb human bioscience s.a.s.
Product description
DECITABINE FOR INJECTION 50MG BORTEZOMIB FOR INJECTION 3.5MG PEMETREXED FOR INJECTION 100MG TEMPERATURE SET AT 22.0 C 71.6 F Expand
Trade date
2026/06/02
B/L No.
78469007341
Suppliers
qilu pharmaceutical hainan co.ltd.
Buyers
ambica international
qilu pharmaceutical hainan co.ltd. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as ondansetron injection,cod,daptomycin.
According to the 52wmb.com global trade database, as of 2026-06-22, the company has completed 889 international trades,
with its main trading regions covering united states,india,colombia etc.
The core products include HS30049099,HS3004902400,HS300490 etc,
often transported via yantian,port 57078, yantian, port hong kong etc,
and its main trading partners are apotex inc.,apotex corp indianpolis,hikma pharmaceuticals plc.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on qilu pharmaceutical hainan co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.